Reid Gift Funds Pancreatic Cancer Early-Detection Program
A $10 million commitment to UT MD Anderson Cancer Center will establish a program aimed at intercepting pancreatic cancer in people at elevated risk.
Updated on Nov. 20, 2026 in Cancer

Live Poll
Should private donors fund more cancer research than they currently do?
Zelma and William Reid committed $10 million to UT MD Anderson Cancer Center to establish the Pancreatic Cancer High-Risk Interception Program, announced November 19, 2026. The program focuses on detecting and intervening against pancreatic cancer in individuals at elevated risk.
Why it matters
Pancreatic cancer is often diagnosed after the disease has already advanced, limiting treatment options. For Houston residents, the program brings a Texas-based early-detection effort to a major local cancer center.
The figure is a single $10 million philanthropic commitment, with no baseline or program enrollment numbers included in the announcement. It is not yet known how many high-risk individuals the program will reach or how its early-detection results will compare with current practice.
The players
UT MD Anderson Cancer Center
A cancer center in Houston, Texas, widely recognized as one of the largest cancer treatment and research institutions in the United States.
Michael P. Kim, M.D.
A physician co-leading the Pancreatic Cancer High-Risk Interception Program at UT MD Anderson Cancer Center.
Manoop S. Bhutani, M.D.
A physician co-leading the Pancreatic Cancer High-Risk Interception Program at UT MD Anderson Cancer Center.
Florencia McAllister, M.D.
A physician co-leading the Pancreatic Cancer High-Risk Interception Program at UT MD Anderson Cancer Center.
The details
The program brings together a multidisciplinary team of experts at UT MD Anderson and combines AI-driven risk assessment, next-generation DNA testing and personalized surveillance. It is co-led by Michael P. Kim, M.D., Manoop S. Bhutani, M.D., and Florencia McAllister, M.D., and includes advanced imaging, molecular diagnostics, a biospecimen and data platform, and training for future leaders in pancreatic cancer prevention. Physicians assess whether a pancreatic cyst is likely to develop into cancer.
Timeline
November 19, 2026: UT MD Anderson announced the $10 million commitment from Zelma and William Reid.
Big Picture
The program extends UT MD Anderson's established pancreatic cancer research into a dedicated high-risk interception model. It applies early-detection methods to a disease that is often found only after it has advanced.
For people with a higher risk of pancreatic cancer, the program offers a path to earlier evaluation and surveillance through advanced imaging and DNA testing. Enrollment details and eligibility criteria were not included in the announcement.
The takeaway
Early detection can change outcomes for diseases that are often caught late, and programs focused on high-risk groups may reach people before symptoms appear. Anyone with concerns about pancreatic cancer risk can ask a physician about screening options.
Further reading
For more on cancer research and prevention efforts, see the Cancer section.
Source note: This article includes information reported by OncLive.
Live Poll
Should private donors fund more cancer research than they currently do?






